{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:14Z","timestamp":1794047354580,"version":"4.8.0"},"reference-count":38,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"5","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Abstract\nSecond malignant neoplasms pose a concern for survivors of childhood cancer.\nWe evaluated incidence, type and risk factors for second malignant neoplasms in patients included in Berlin-Frankfurt-Muenster protocols for childhood non-Hodgkin lymphoma.\n3590 patients<\/jats:p>","DOI":"10.3324\/haematol.2019.244780","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T17:35:15Z","timestamp":1587058515000},"page":"1390-1400","source":"Crossref","is-referenced-by-count":11,"title":["Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group"],"prefix":"10.3324","volume":"106","author":[{"family":"Olga Moser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Martin Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ulrike Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Wolfram Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ilske Oschlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Martin Schrappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Andishe Attarbaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Georg Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Felix Niggli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Claudia Spix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Udo Kontny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Thomas Klingebiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Alfred Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Birgit Burkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Wilhelm Woessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"25176","doi-asserted-by":"crossref","unstructured":"de Vathaire F, Hawkins M, Campbell S. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer. 1999; 79(11-12):1884-1893.","DOI":"10.1038\/sj.bjc.6690300"},{"key":"25177","doi-asserted-by":"crossref","unstructured":"Inskip P, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer. 2007; 121(10):2233-2240.","DOI":"10.1002\/ijc.22827"},{"key":"25178","doi-asserted-by":"crossref","unstructured":"Meadows AT, Friedman DL, Neglia JP. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study Cohort. J Clin Oncol. 2009; 27(14):2356-2362.","DOI":"10.1200\/JCO.2008.21.1920"},{"key":"25179","doi-asserted-by":"crossref","unstructured":"Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016; 122(1):116-123.","DOI":"10.1002\/cncr.29685"},{"key":"25180","doi-asserted-by":"crossref","unstructured":"Turcotte LM, Liu Q, Yasui Y. Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort. J Clin Oncol. 2019; 37(34):3310-3319.","DOI":"10.1200\/JCO.19.00129"},{"key":"25181","unstructured":"Scholz-Kreisel P, Kaatsch P, Spix C. Second malignancies following childhood treatment in Germany from 1980 to 2014 - a registry-based analysis. Dtsch Arztebl Int. 2018; 115(23):385-392."},{"key":"25182","doi-asserted-by":"crossref","unstructured":"Turcotte LM, Whitton JA, Friedman DL. Risk of subsequent neoplasms during the fifth and sixth decades of life in the Childhood Cancer Survivor Study Cohort. J Clin Oncol. 2015; 33(31):3568-3575.","DOI":"10.1200\/JCO.2015.60.9487"},{"key":"25183","doi-asserted-by":"crossref","unstructured":"Friedman DL, Whitton J, Leisenring W. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010; 102(14):1083-1095.","DOI":"10.1093\/jnci\/djq238"},{"key":"25184","doi-asserted-by":"crossref","unstructured":"Bluhm EC, Roncers C, Hayashi RJ. Cause specific mortality and second cancer incidence after non Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2008; 111(8):4014-2021.","DOI":"10.1182\/blood-2007-08-106021"},{"key":"25185","doi-asserted-by":"crossref","unstructured":"Leung W, Sandlund JT, Hudson MM. Second Malignancy after treatment of childhood Non-Hodgkin Lymhoma. Cancer. 2001; 92(7):1959-1966.","DOI":"10.1002\/1097-0142(20011001)92:7<1959::AID-CNCR1715>3.0.CO;2-Y"},{"key":"25186","doi-asserted-by":"crossref","unstructured":"Ehrhardt MJ, Chen Y, Sandlund JT. Late health outcomes after contemporary lymphome Malin de Burkitt therapy for mature B-cell non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2019; 37(28):2556-2570.","DOI":"10.1200\/JCO.19.00525"},{"key":"25187","doi-asserted-by":"crossref","unstructured":"Ehrhardt MJ, Sandlund JT, Zhang N. Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: a report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2017; 64(6)","DOI":"10.1002\/pbc.26338"},{"key":"25188","doi-asserted-by":"crossref","unstructured":"Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 2006; 107(1):108-115.","DOI":"10.1002\/cncr.21971"},{"key":"25189","doi-asserted-by":"crossref","unstructured":"Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S. Risk for second malignancies in non-Hodgkin\u2019s lymphoma survivors: a meta-analysis. Ann Oncol. 2011; 2(8):1845-1858.","DOI":"10.1093\/annonc\/mdq697"},{"key":"25190","doi-asserted-by":"crossref","unstructured":"Lennert K, Stein H, Kaiserling E. Cytological and functional criteria for the classification of malignant lymphoma. Br J Cancer. 1975; 31(Suppl 2):29-43.","DOI":"10.1111\/j.1365-2141.1975.tb00911.x"},{"key":"25191","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Stein H. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84(5):1361-1392.","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"25192","unstructured":"World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 2001."},{"key":"25193","unstructured":"Murphy SB. Classification, staging and end results of treatment in childhood non Hodgkin\u2019s lymphoma: dissimilarities from lymphomas in adults. Semin Oncol. 1980; 7(3):332-339."},{"key":"25194","doi-asserted-by":"crossref","unstructured":"Woessmann W, Seidemann K, Mann G. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with Bcell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005; 105:948-958.","DOI":"10.1182\/blood-2004-03-0973"},{"key":"25195","doi-asserted-by":"crossref","unstructured":"Seidemann K, Tiemann M, Schrappe M. Short-pulse B-non-Hodgkin lymphomatype chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt- Munster Group Trial NHL-BFM 90. Blood. 2001; 97(12):3699-3706.","DOI":"10.1182\/blood.V97.12.3699"},{"key":"25196","unstructured":"Reiter A, Schrappe M, Tiemann M. Improved treatment results in childhood Bcell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt- Munster Group Trial NHL-BFM 90. Blood. 1999; 94(10):3294-3306."},{"key":"25197","doi-asserted-by":"crossref","unstructured":"Reiter A, Schrappe M, Tiemann M. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin- Frankfurt-Munster group studies. J Clin Oncol. 1994; 12(5):899-908.","DOI":"10.1200\/JCO.1994.12.5.899"},{"key":"25198","doi-asserted-by":"crossref","unstructured":"Reiter A, Schrappe M, Ludwig WD. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood. 1992; 80(10):2471-2478.","DOI":"10.1182\/blood.V80.10.2471.2471"},{"key":"25199","unstructured":"Kalbfleisch J, Prentice RL. The statistical analysis of failure time data. 1980;163."},{"key":"25200","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53(282):457-481.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"25201","doi-asserted-by":"crossref","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17(12):2257-2317.","DOI":"10.1038\/sj.leu.2403202"},{"key":"25202","doi-asserted-by":"crossref","unstructured":"Leone G, Voso MT, Sica S, Morosetti and Pagano L. Therapy related leukemias: susceptibility, prevention and treatment. Leuk Lymphoma. 2001; 41(3-4):255-276.","DOI":"10.3109\/10428190109057981"},{"key":"25203","doi-asserted-by":"crossref","unstructured":"Pui CH, Relling MV. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol. 2000; 109(1):13-23.","DOI":"10.1046\/j.1365-2141.2000.01843.x"},{"key":"25204","doi-asserted-by":"crossref","unstructured":"L\u00f6ning L, Zimmermann M, Reiter A. Secondary neoplasms subsequent to Berlin- Frankfurt-M\u00fcnster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood. 2000; 95(9):2770-2775.","DOI":"10.1182\/blood.V95.9.2770.009k16_2770_2775"},{"key":"25205","doi-asserted-by":"crossref","unstructured":"Paganin M, Buldini B, Germano G. A Case of T-cell Acute Lymphoblastic Leukemia Relapsed As Myeloid Acute Leukemia. Pediatr Blood Cancer. 2016; 63(9):1660-1663.","DOI":"10.1002\/pbc.26054"},{"key":"25206","doi-asserted-by":"crossref","unstructured":"Maule M, Scelo G, Pastore G. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst. 2007; 99(10):790-800.","DOI":"10.1093\/jnci\/djk180"},{"key":"25207","doi-asserted-by":"crossref","unstructured":"Relling MV, Rubnitz JE, Rivera GK. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet. 1999; 354(9172):34-39.","DOI":"10.1016\/S0140-6736(98)11079-6"},{"key":"25208","doi-asserted-by":"crossref","unstructured":"Ripperger T, Schlegelberger B. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome. Eur J Med Genet. 2016; 59(3):133-142.","DOI":"10.1016\/j.ejmg.2015.12.014"},{"key":"25209","doi-asserted-by":"crossref","unstructured":"Wimmer K, Kratz CP, Vasen HF. EUConsortium Care for CMMRD (C4CMMRD). Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD). J Med Genet. 2014; 51(6):355-365.","DOI":"10.1136\/jmedgenet-2014-102284"},{"key":"25210","doi-asserted-by":"crossref","unstructured":"Attarbaschi A, Carraro E, Abla O. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents. Haematologica. 2016; 101(12):1581-1591.","DOI":"10.3324\/haematol.2016.147116"},{"key":"25211","doi-asserted-by":"crossref","unstructured":"Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2010; 19(7):1686-1695.","DOI":"10.1158\/1055-9965.EPI-10-0243"},{"key":"25212","doi-asserted-by":"crossref","unstructured":"Levine AM. Lymphoma complicating immunodeficiency disorders. Ann Oncol. 1994; 5(Suppl 2):S29-35.","DOI":"10.1093\/annonc\/5.suppl_2.S29"},{"key":"25213","doi-asserted-by":"crossref","unstructured":"Ripperger T, Bielack SS, Borkhardt A. Childhood cancer predisposition syndromes- A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet. 2017; 173(4):1017-1037.","DOI":"10.1002\/ajmg.a.38142"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9720\/70781","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9720\/70782","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9720\/70781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:56:47Z","timestamp":1794045407000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,4,30]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2019.244780","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}